NEO-PV-01: Ph Ib started

Neon began an open-label, U.S. Phase Ib trial to evaluate subcutaneous NEO-PV-01 plus Opdivo nivolumab in about 90 patients with melanoma, non-small cell lung cancer (NSCLC) or bladder cancer. Patient...